BRCA1 protein expression level and CD44+ phenotype in breast cancer patients

Cell Journal

Volumn 13, Issue 3, 2011, Pages 155-162

  Madjd, Zahra ^a   Karimi, Adel ^a   Molanae, Saadat ^b   Asadi Lari, Mohsen ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MILAD HOSPITAL   (Iran)

Author keywords

BRCA1; Breast cancer; Cancer stem cells; Immunohistochemistry

Indexed keywords

BRCA1 PROTEIN; CELL MARKER; HERMES ANTIGEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER STEM CELL; CELL NUCLEUS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENE LOSS; GENE MUTATION; GENETIC ASSOCIATION; HETEROZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PHENOTYPE; PROGNOSIS;

EID: 83455205811     PISSN: 22285806     EISSN: 22285814     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001; 94(2): 153-156. (Pubitemid 32911406)
2. Bennett IC, Gattas M, Teh BT. The genetic basis of breast cancer and its clinical implications. Aust N Z J Surg. 1999; 69(2) :95-105. (Pubitemid 29082822)
3. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994; 266(5182): 66-71. (Pubitemid 24345325)
4. Ellisen LW, Haber DA. Hereditary breast cancer. Annu Rev Med. 1998; 49: 425-436. (Pubitemid 28197464)
5. Keshavarzi F, Javadi GHR, Nafissi N, Akbari ME, Yasaei VR, Sharafi Farzad M, et al. BRCA1 and BRCA2 Genetic Testing in Breast and/or Ovarian Cancer Families in Iran. Yakhteh. 2010; 12(3): 329-340.
6. Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea - a paradigm shift. Cancer Res. 2006; 66(4): 1883-1890; discussion18 95-1896.
7. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003; 100(7):3983-3988. (Pubitemid 36418143)
8. Costa FF, Le Blanc K, Brodin B. Concise review: cancer/testis antigens, stem cells, and cancer. Stem Cells. 2007; 25(3): 707-711. (Pubitemid 46354230)
9. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005; 65(23): 10946-10951. (Pubitemid 41713363)
10. Matsui W, Huff CA, Wang Q, Malehorn MT, Barber J, Tanhehco Y, et al. Characterization of clonogenic multiple myeloma cells. Blood. 2004; 103(6): 2332-2336. (Pubitemid 38326254)
11. Foulkes WD. BRCA1 functions as a breast stem cell regulator. J Med Genet. 2004; 41(1): 1-5. (Pubitemid 38125677)
12. Liu S, Ginestier C, Charafe-Jauffret E, Foco H, Kleer CG, Merajver SD, et al. BRCA1 regulates human mammary stem/progenitor cell fate. Proc Natl Acad Sci USA. 2008; 105(5): 1680-1685. (Pubitemid 351346574)
13. Bradley A, Medina D. Introduction: BRCA1 and BRCA2 in mammary gland development and tumorigenesis. J Mammary Gland Biol Neoplasia. 1998; 3(4): 363-364.
14. Russo J, Lynch H, Russo IH. Mammary gland architecture as a determining factor in the susceptibility of the human breast to cancer. Breast J. 2001; 7(5): 278-291. (Pubitemid 33101632)
15. Deng CX. BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res. 2006; 34(5): 1416-1426.
16. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007; 1(5): 555-567. (Pubitemid 350056407)
17. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell. 2007; 131(6): 1109-1123. (Pubitemid 350235025)
18. Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV, Varticovski L. Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res. 2008;10(1):R10.
19. Pinder SE, Ellis IO, Galea M, O'Rouke S, Blamey RW, Elston CW. Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up. Histopathology. 1994; 24(1): 41-47. (Pubitemid 24223138)
20. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991; 19(5): 403-410.
21. Ellis IO, Galea M, Broughton N, Locker A, Blamey RW, Elston CW. Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology. 1992; 20(6): 479-489.
22. Madjd Z, Mehrjerdi AZ, Sharifi AM, Molanaei S, Shahzadi S, Asadi-Lari M. CD44+ cancer cells express higher levels of the anti-apoptotic protein Bcl-2 in breast tumours. Cancer Immun. 2009; 9(4): 1-7.
23. Rakha EA, El-Sheikh SE, Kandil MA, El-Sayed ME, Green AR, Ellis IO. Expression of BRCA1 protein in breast cancer and its prognostic significance. Hum Pathol. 2008; 39(6): 857-865.
24. McCarty KS J., Miller LS, Cox EB, Konrath J, McCarty KS Sr. Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med. 1985; 109(8): 716-721. (Pubitemid 16237466)
25. Wicha MS. Cancer stem cell heterogeneity in hereditary breast cancer. Breast Cancer Res. 2008; 10(2): 105.
26. Abraham BK, Fritz P, McClellan M, Hauptvogel P, Athelogou M, Brauch H. Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin Cancer Res. 2005; 11(3): 1154-1159.
27. Lambie H, Miremadi A, Pinder SE, Bell JA, Wencyk P, Paish EC, et al. Prognostic significance of BRCA1 expression in sporadic breast carcinomas. J Pathol. 2003; 200(2): 207-213. (Pubitemid 36748029)
28. Wilson CA, Ramos L, Villasenor MR, Anders KH, Press MF, Clarke K, et al. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat Genet. 1999; 21(2): 236-240. (Pubitemid 29070375)
29. Lee WY, Jin YT, Chang TW, Lin PW, Su IJ. Immunolocalization of BRCA1 protein in normal breast tissue and sporadic invasive ductal carcinomas: a correlation with other biological parameters. Histopathology. 1999; 34(2): 106-112.
30. Yoshikawa K, Honda K, Inamoto T, Shinohara H, Yamauchi A, Suga K, et al. Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases. Clin Cancer Res. 1999; 5(6): 1249-1261. (Pubitemid 29282927)
31. Coene E, Van Oostveldt P, Willems K, van Emmelo J, De Potter CR. BRCA1 is localized in cytoplasmic tube-like invaginations in the nucleus. Nat Genet. 1997; 16(2): 122-124. (Pubitemid 27240610)
32. Taylor J, Lymboura M, Pace PE, A'hern RP, Desai AJ, Shousha S, et al. An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers. Int J Cancer. 1998; 79(4): 334-342. (Pubitemid 28359729)
33. Foulkes WD, Metcalfe K, Hanna W, Lynch HT, Ghadirian P, Tung N, et al. Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma. Cancer. 2003; 98(8): 1569-1577. (Pubitemid 37238611)
34. Fraser JA, Reeves JR, Stanton PD, Black DM, Going JJ, Cooke TG, et al. A role for BRCA1 in sporadic breast cancer. Br J Cancer. 2003; 88(8): 1263-1270. (Pubitemid 36606344)
35. Honeth G, Bendahl PO, Ringner M, Saal LH, Gruvberger-Saal SK, Lovgren K, et al. The CD44+/CD24- phenotype is enriched in basal-like breast tumors. Breast Cancer Res. 2008; 10(3): R53.
36. Balic M, Lin H, Young L, Hawes D, Giuliano A, McNamara G, et al. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res. 2006; 12(19): 5615-5621. (Pubitemid 44629587)